Atrial fibrillation is the most frequent occurring sustained cardiac arrhythmia and it is related
to common cardiac disease conditions. Hypertension increases the risk of atrial fibrillation by …

Hypertension (1) and atrial fibrillation (2, 3) both increase with age. Both hypertension and
atrial fibrillation are associated with an increased incidence of stroke, heart failure, and …

Background: In VALUE the impact of antihypertensive treatment with valsartan and
amlodipine on cardiovascular morbidity and mortality was neutral despite lower BP on …

Atrial fibrillation is the most common clinically significant cardiac arrhythmia and is
associated with markedly increased risks of cardiovascular diseases. Atrial fibrillation and …

The inhibition of the renin‐angiotensin system has demonstrated both experimental and
clinical effects in preventing atrial fibrillation. However, there is still uncertainty about the role …

We aimed to investigate the effectiveness and safety of angiotensin-converting enzyme
inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on preventing atrial fibrillation …

Atrial arrhythmias, ventricular arrhythmias, and sudden cardiac death (SCD) are significant
health problems and an economic burden to society. The renin‐angiotensin‐aldosterone …

Atrial fibrillation (AF) is an emerging public health problem. The most important risk factor for
developing chronic AF is uncontrolled hypertension. Uncontrolled hypertension promotes …

The renin-angiotensin-aldosterone system (RAAS) has emerged as an important hormonal
system in the initiation and pathogenesis of atrial fibrillation (AF). Therefore, angiotensin …

Aims To examine the associations between antihypertensive treatment with angiotensin-
converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs), β-blockers …